Basel Medical
BMGL
4 hedge funds and large institutions have $32.2K invested in Basel Medical in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.04% less ownership
Funds ownership: 0.06% → 0.02% (-0.04%)
54% less capital invested
Capital invested by funds: $70.2K → $32.2K (-$38K)
56% less funds holding
Funds holding: 9 → 4 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
T3 Companies
New York
|
+$9.89K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$16.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$12.1K |
| 3 |
Jane Street
New York
|
-$7.98K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7.49K |
| 5 |
Renaissance Technologies
New York
|
-$7.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $15.7K | -$3.08K | -390 | -15% |
|
|
TC
2
T3 Companies
New York
| $8.85K | +$9.89K | +1,250 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $7.7K | +$3.27K | +414 | +61% |
|
|
GSC
4
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$16.5K | -2,809 | Closed |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$12.1K | -2,056 | Closed |
|
|
6
Jane Street
New York
| – | -$7.98K | -1,357 | Closed |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7.49K | -1,274 | Closed |
|
|
8
Renaissance Technologies
New York
| – | -$7.1K | -1,208 | Closed |
|
|
BIA
9
Bell Investment Advisors
Oakland,
California
| – | -$122 | -21 | Closed |
|
BMGL Hedge Fund Activity: Q1 2026 in Review
4 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q1 2026, worth a combined $32.2K — down 54% from $70.2K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BMGL and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was T3 Companies, opening a new position worth an estimated $9.89K. The largest seller was Ground Swell Capital, exiting entirely with an estimated $16.5K sold.
- 4 institutional investors held Basel Medical (BMGL) as of Q1 2026, down from 9 in Q4 2025.
- Funds reported $32.2K of Basel Medical stock for Q1 2026, down 54% quarter-over-quarter.
- 1 fund opened new Basel Medical positions in Q1 2026 and 6 closed out, a net change of -5 holders.
- The largest Basel Medical buyer in Q1 2026 was T3 Companies, an estimated $9.89K added.
- The largest Basel Medical seller in Q1 2026 was Ground Swell Capital, an estimated $16.5K sold.
Based on aggregated 13F filings for Q1 2026.